Clinical Trial Update: A Trial of Surgery and Fractionated Re-Irradiation for Recurrent Ependymoma [Phase 2]

View source ↗

Summary

Phase 2 trial from St. Jude evaluating surgery followed by fractionated re-irradiation for recurrent ependymoma; results posted on 2024-11-12.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ependymoma

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Ependymoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-11-12